Patient perceptions of stool DNA testing for pan-digestive cancer screening: A survey questionnaire

por Yang, Dennis, Hillman, Shauna L, Harris, Ann M, Sinicrope, Pamela S, Devens, Mary E, Ahlquist, David A
Publicado 2014

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

por Jatoi, Aminah, Hillman, Shauna L, Ziegler, Katie L Allen, Stella, Philip J, Soori, Gamini S, Rowland, Kendrith M
Publicado 2009

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials

por Le-Rademacher, Jennifer G., Hillman, Shauna, Storrick, Elizabeth, Mahoney, Michelle R., Thall, Peter F., Jatoi, Aminah, Mandrekar, Sumithra J.
Publicado en Cancers (Basel) (2020)

Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation

por Hillman, Shauna L., An, Ming-Wen, O'Connell, Michael J., Goldberg, Richard M., Schaefer, Paul, Buckner, Jan C., Sargent, Daniel J.
Publicado 2009

Radiofrequency Ablation of Medically Inoperable Stage IA Non–Small Cell Lung Cancer: Are Early Posttreatment PET Findings Predictive of Treatment Outcome?

por Yoo, Don C., Dupuy, Damian E., Hillman, Shauna L., Fernando, Hiran C., Rilling, William S., Shepard, Jo-Anne O., Siegel, Barry A.
Publicado 2011

Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trials

por An, Ming-Wen, Mandrekar, Sumithra J., Branda, Megan E., Hillman, Shauna L., Adjei, Alex A., Pitot, Henry, Goldberg, Richard M., Sargent, Daniel J.
Publicado 2011

Radiofrequency Ablation of Stage IA NSCLC in Medically Inoperable Patients: Results from the ACOSOG Z4033 (Alliance) Trial

por Dupuy, Damian E., Fernando, Hiran C., Hillman, Shauna, Ng, Thomas, Tan, Angelina D., Sharma, Amita, Rilling, William S., Hong, Kelvin, Putnam, Joe B.
Publicado en Cancer (2015)

Impact of Disease Progression Date Determination on Progression-free Survival Estimates in Advanced Lung Cancer

por Qi, Yingwei, Ziegler, Allen, Katie, L., Hillman, Shauna L., Redman, Mary W., Schild, Steven E., Gandara, David R., Adjei, Alex A., Mandrekar, Sumithra J.
Publicado 2012

Evaluation of the Value of Attribution in the Interpretation of Adverse Event Data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group Investiga...

por Hillman, Shauna L., Mandrekar, Sumithra J., Bot, Brian, DeMatteo, Ronald P., Perez, Edith A., Ballman, Karla V., Nelson, Heidi, Buckner, Jan C., Sargent, Daniel J.
Publicado 2010

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

por Boughey, Judy C., Snyder, Rebecca A., Kantor, Olga, Zheng, Linda, Chawla, Akhil, Nguyen, Toan T., Hillman, Shauna L., Hahn, Olwen M., Mandrekar, Sumithra J., Roland, Christina L.
Publicado en Ann Surg Oncol (2021)

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer: A North Central Cancer...

por Bryce, Alan H., Mattar, Bassam, Hillman, Shauna L., Adjei, Alex A., Kugler, John W., Rowland, Kendrith, Wender, Donald B., Soori, Gamini, Perez, Edith A., Jett, James R.
Publicado en Am J Clin Oncol (2010)

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION FOR UNRESECTABLE NON–SMALL CELL LUNG CANCER: NCCTG N0028 (ALLIANCE)

por Schild, Steven E., Hillman, Shauna L., Tan, Angelina D., Ross, Helen J., McGinnis, William L., Garces, Yolanda A., Graham, David L., Adjei, Alex A., Jett, James R.
Publicado en J Thorac Oncol (2017)

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326()...

por Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Publicado en Cancer (2010)

Endpoints in Phase II trials for advanced non-small cell lung cancer

por Mandrekar, Sumithra J., Qi, Yingwei, Hillman, Shauna L., Allen Ziegler, Katie L., Reuter, Nicholas F., Rowland, Kendrith M., Kuross, Steven A., Marks, Randolph S., Schild, Steven E., Adjei, Alex A.
Publicado 2010

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

por Mc Kean, Heidi, Stella, Philip J., Hillman, Shauna L., Rowland, Kendrith M., Cannon, Michael W., Behrens, Robert J., Gross, Gerald G., Sborov, Mark D., Friedman, Eliot L., Jatoi, Aminah
Publicado en Cancer Invest (2011)

Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Ba...

por Yang, Ping, Mandrekar, Sumithra J., Hillman, Shauna H., Allen Ziegler, Katie L., Sun, Zhifu, Wampfler, Jason A., Cunningham, Julie M., Sloan, Jeff A., Adjei, Alex A., Perez, Edith, Jett, James R.
Publicado 2009

The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea in High-risk Operable Patients; Preliminary results from the ACOSOG Z4032 Trial

por Fernando, Hiran C, Landreneau, Rodney J, Mandrekar, Sumithra J, Hillman, Shauna L, Nichols, Francis C, Meyers, Bryan, DiPetrillo, Thomas A, Heron, Dwight, Jones, David R, Daly, Benedict D T, Starnes, Sandra L, Hatter, Jeffrey E, Putnam, Joe B
Publicado 2011

Thirty and Ninety Day Outcomes after Sublobar Resection with and without brachytherapy for Non-small cell lung cancer: Results from a Multicenter Phase III study

por Fernando, Hiran C, Landreneau, Rodney J, Mandrekar, Sumithra J, Hillman, Shauna L, Nichols, Francis C, Meyers, Bryan, DiPetrillo, Thomas A, Heron, Dwight E, Jones, David R, Daly, Benedict D T, Starnes, Sandra L, Tan, Angelina, Putnam, Joe B
Publicado 2011

Analysis of longitudinal quality of life data in high-risk operable patients with lung cancer: Results from ACOSOG Z4032 (Alliance) a multicenter randomized trial

por Fernando, Hiran C, Landreneau, Rodney J, Mandrekar, Sumithra J, Nichols, Francis C, DiPetrillo, Thomas A, Meyers, Bryan F, Heron, Dwight E, Hillman, Shauna, Jones, David R, Starnes, Sandra L, Tan, Angelina D, Daly, Benedict D T, Putnam, Joe B
Publicado en J Thorac Cardiovasc Surg (2014)

Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell...

por Fernando, Hiran C., Landreneau, Rodney J., Mandrekar, Sumithra J., Nichols, Francis C., Hillman, Shauna L., Heron, Dwight E., Meyers, Bryan F., DiPetrillo, Thomas A., Jones, David R., Starnes, Sandra L., Tan, Angelina D., Daly, Benedict D.T., Putnam, Joe B.
Publicado 2014